Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic out- comes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation. 2008;118:1626 36. 619. James S, Angiolillo DJ, Cornel JH, et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2010;31:3006 16. 620. Waters DD, Walling A, Roy D, et al. Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. Am J Cardiol. 1986;58:465 9. 621. Kleiman NS, Anderson HV, Rogers WJ, et al. Comparison of outcome of patientswithunstableanginaandnon-Q-waveacutemyocardialinfarction Amsterdam et al 2014 AHA/ACC NSTE-ACS Guideline e409 with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry). Am J Cardiol. 1996;77:227 31. 622. Labinaz M, Kilaru R, Pieper K, et al. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation. 2002;105:322 7. 623. Brilakis ES, de Lemos JA, Cannon CP, et al. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). Am J Cardiol. 2008;102:552 8. 624. Labinaz M, Mathias J, Pieper K, et al. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary interven- tion: a pooled analysis of three randomized clinical trials. Eur Heart J. 2005;26:128 36. 625. Kim MS, Wang TY, Ou FS, et al. 